Log In
Print
BCIQ
Print
Print this Print this
 

NovoSeven, eptacog alfa (activated) (NovoSeven RT)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionRoom temperature stable formulation of recombinant human coagulation Factor VIIa
Molecular Target Factor VIIa
Mechanism of ActionProcoagulant
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat and prevent hemophilia; Treat bleeding episodes and for perioperative management in adults and children with Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today